Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Shorook Na'ara Image

      Shorook Na'ara, MD,PHD

      Department of Head and Neck Surgery, Division of Surgery

      About Dr. Shorook Na'ara

      Dr. Shorook Naara is an Assistant Professor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Naara is a head and neck surgical oncologist with clinical expertise in oral cavity cancer, oropharyngeal cancer, transoral robotic surgery (TORS), cutaneous squamous cell carcinoma, and endocrine surgery.


      Dr. Naara’s research interests focus on translational immuno-oncology and tumor microenvironment biology in head and neck and skin cancers. Her work integrates spatial and single-cell technologies to study mechanisms of immunotherapy response and resistance, biomarker discovery, and immunoprevention strategies in oral potentially malignant disorders.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Head and Neck Surgery, Surgery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2018Ruth & Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Haifa District, IL, PhD
      2015Ruth & Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, IL, Cancer Research, MSc
      2012Ruth & Bruce Rappaport Faculty of Medicine, Technion, Israel Insitute of Technology, Haifa, Haifa District, IL, M.D
      2008Ruth & Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Haifa District, IL, BSc

      Postgraduate Training

      2023-2025Head and Neck Surgical Oncology Fellow, The University of Texas, MD Anderson Cancer Center, Houston, Texas
      2021-2023Postdoctoral Fellow, University of California San Francisco Medical Center, San Francisco, California
      2017-2021Chief Resident, Otolaryngology, Rambam Health Care Campus, Haifa
      2017-2021Staff Researcher, Technion – Israel Institute of Technology, Haifa
      2015-2021Resident, Otolaryngology, Rambam Health Care Campus, Haifa
      2012-2013Intern, Rambam Health Care Campus, Haifa
      2009-2012Doctor's Assistant, Rambam Health Care Campus, Haifa
      2009-2012Doctor's Assistant, Rambam Health Care Campus, Haifa

      Experience & Service

      Editorial Activities

      Editorial Board Member, Advanced Biology

      Honors & Awards

      2024 - PresentConquer Cancer Merit Award, The ASCO Foundation
      2021 - 2024Israel National Postdoctoral Award Committee for Advancing Women in Science, Weizmann Institute of Science
      2021 - 2023VATAT, Israel Council for Higher Education
      2018Best Resident Research Award, The Israeli Society of Head and Neck Surgery and Oncology
      2015Excellence Scholarship for PhD Research, Rappaport Faculty of Medicine, Technion, Haifa Israel

      Professional Memberships

      The American Society of Clinical Oncology

      2024 - Present

      American Head and Neck Society

      2022 - Present

      American Association for Cancer Research

      2016 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2025. Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: The MD Anderson Experience. AHNS Annual Meeting. New Orleans, Louisiana, US.
      2. 2024. Intralesional nivolumab in oral potentially malignant disorders: A phase 1 pilot study on safety, tolerability, and preliminary efficacy. ASCO Annual Meeting. Chicago, Illinois, US.
      3. 2024. Response-Adapted Oncologic Surgery for Cutaneous Squamous Cell Carcinoma: Personalized Approach in the Immunotherapy Era. AHNS Annual Meeting. Chicago, Illinois, US.
      4. 2020. The impact of a Multidisciplinary team approach in a tertiary referral center on the management of Vestibular Schwannoma patients. Poster. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      5. 2020. Outcome of patients with recurrent and/ or metastatic head and neck cancer treated with immunotherapy: a single center experience. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      6. 2020. Incorporating perineural invasion to tumor classification of oral cancer: an international study. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      7. 2020. Iatrogenic Oropharyngeal Dysphagia in Head and Neck Patients. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      8. 2018. Efficacy of post-treatment radioiodine scanning in patients with differentiated thyroid cancer. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      9. 2018. Cold Versus Hot Adenoidectomy: A Prospective Randomized Trial. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      10. 2018. Submucosal Resection Vs Endoscopic Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      11. 2018. Do Senior Specialists Have Better Results Than Residents in Performing Tonsillectomy?. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      12. 2018. The post translational effect of PIGU on the sodium iodide symporter in well differentiated thyroid carcinoma. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology. Kfar Blum, IL.
      13. 2018. The correlation between PIGU expression and radioactive iodine resistance in patients with well differentiated thyroid cancer. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology. Kfar Blum, IL.
      14. 2016. The role of GPIT complex in well differentiated thyroid cancer. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      15. 2016. Mechanisms of radioiodine resistance in well differentiated thyroid cancer. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology. Hagoshrem, IL.
      16. 2015. Benchmark Values of the Minimal Clinically Important Difference in Quality of Life Scores of Patients with Laryngeal Cancer. The Annual Conference of the Israeli Society of Head and Neck Surgery and Oncology. Hagoshrem, IL.
      17. 2015. Plasmacytoma of the Skull Base. Poster. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      18. 2015. Benchmark Values of the Minimal Clinically Important Difference in Quality of Life Scores of Patients with Laryngeal Cancer. Poster. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      19. 2014. Surgical Treatment of Locally Advanced Thyroid Cancer. Head and Neck Surgery Annual Meeting. Eliat, IL.
      20. 2014. Treatment and Outcome of Patients with Skull Base Chordoma: A Meta-analysis. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.
      21. 2014. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis. Head and Neck Surgery Annual Meeting. Eilat, Southern District, IL.

      International Presentations

      1. 2022. Mechanobiological Aspects of Cancerous Neural Invasion. Cancer Neuroscience A Novel, Actionable Hallmark of Cancer Symposium. Houston, US.
      2. 2019. Incorporating perineural invasion to tumor classification of oral cancer: an international study. 7th WORLD CONGRESS of the International Academy of Oral Oncology, IAOO. Rome, IL.
      3. 2019. L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression. The Neural Influences in Cancer Think-Tank Meeting. Heidelberg, DE.
      4. 2016. PIGU Modulates Radioactive Iodine Uptake in Differentiated Thyroid Cancers. Poster. AACR Annual Meeting. New Orleans, US.
      5. 2016. Paracrine Interactions Between Schwann Cells and Cancer Cells Promotes Perineural Invasion via L1CAM Secretion. Poster. AACR Annual Meeting. New Orleans, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Shinnawi S, Matanis W, Noy R, Na'ara S, Cohen-Vaizer M, Cohen JT, Gordin AJ. Does the level of surgical training influence tonsillectomy outcomes? A prospective randomized study. Laryngol Otol, 2025. e-Pub 2025.
      2. Yaniv D, Na'ara S, Netto FOG, Stafford H, Buell J, Chiang E, Shahrukh A, Li S, Nagarajan P, Hanna EY, Gross ND, Amit M. Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant Immunotherapy. Ann Surg Oncol, 2025. e-Pub 2025.
      3. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Na'ara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallón de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature, 2025. e-Pub 2025.
      4. Na'ara S, Shinnawi S, Habashi N, Rimmer E, Billan S, Cohen JT. Evaluation and Outcomes of Iatrogenic Oropharyngeal Dysphagia. Clin Otolaryngol, 2025. e-Pub 2025.
      5. Nguyen J, Naara S, Woerner L, VanLandingham N, Hoerner M, Santuray R, Blum K, Kim M, Johnson D, Grandis J. Blockade of the PGE2 pathway inhibits the growth of PTEN deficient HNSCC tumors. Molecular Cancer Therapuetics, 2025. e-Pub 2025.
      6. Na'ara S, Cui Z, Izgutdina A, VanLandingham NK, Nazarenko A, Woerner LC, Hua Fu BX, Gilbert LA, Johnson DE, Grandis JR. Neddylation as a target in PIK3CA-mutated head and neck cancer. Biochem Biophys Res Commun, 2025. e-Pub 2025.
      7. de Almeida JR, Hueniken K, Xie M, Monteiro E, Zadeh G, Kalyvas A, Gullane P, Snyderman C, Wang E, Gardner P, Fliss D, Ringel B, Gil Z, Na'ara S, Ooi E, Goldstein D, Witterick I. Multi-Institutional Comparison of Quality of Life Between Open Versus Endoscopic Skull Base Approaches. Laryngoscope Investig Otolaryngol, 2025. e-Pub 2025.
      8. Li S, Townes T, Na'ara S. Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients. Cancers, 2024. e-Pub 2024.
      9. Na'ara S, Andrews C, Sikora A, Williams M, Chambers M, Myers J, Amit M. Oral Premalignancy: An Update on Novel Therapeutic Approaches. Curr Oncol Rep, 2024. e-Pub 2024.
      10. Amit M, Anastasaki C, Dantzer R, Demir IE, Deneen B, Dixon K, Egeblad M, Gibson EM, Hervey-Jumper S, Hondermarck H, Magnon C, Monje M, Na'ara S, Pan Y, Repasky E, Scheff N, Sloan E, Talbot S, Tracey K, Trotman L, Valiente M, Van Aelst L, Venkataramani V, Venkatesh H, Vermeer P, Winkler F, Wong R, Gutmann D, and Borniger J. Next directions in the neuroscience of cancers arising outside the CNS. Cancer Discov, 2024. e-Pub 2024.
      11. Kuan EC, Wang EW, Adappa ND, Beswick DM, Jr LN, Su SY, Wang MB, Abuzeid WM, Alexiev B, Alt JA, Antognoni P, Alonso-Basanta M, Batra PS, Bhayani M, Bell D, Bernal-Sprekelsen M, Betz CS, Blay JY, Bleier BS, Bonilla-Velez J, Callejas C, Carrau RL, Casiano RR, Castelnuovo P, Chandra RK, Chatzinakis V, Chen SB, Chiu AG, Choby G, Chowdhury NI, Citardi MJ, Cohen MA, Dagan R, Dalfino G, Dallan I, Dassi CS, de Almeida J, Dei Tos AP, DelGaudio JM, Ebert CS, El-Sayed IH, Eloy JA, Evans JJ, Fang CH, Farrell NF, Ferrari M, Fischbein N, Folbe A, Fokkens WJ, Fox MG, Lund VJ, Gallia GL, Gardner PA, Geltzeiler M, Georgalas C, Getz AE, Govindaraj S, Gray ST, Grayson JW, Gross BA, Grube JG, Guo R, Ha PK, Halderman AA, Hanna EY, Naara S, Harvey RJ, Hernandez SC, Holtzman AL, Hopkins C, Huang Z, Huang Z, Humphreys IM, Hwang PH, Iloreta AM, Ishii M, Ivan ME, Jafari A, Kennedy DW, Khan M, Kimple AJ, Kingdom TT, Knisely A, Kuo YJ, Lal D, Lamarre ED, Lan MY, Le H, Lechner M, Lee NY, Lee JK, Lee VH, Levine CG, Lin JC, Lin DT, Lobo BC, Locke T, Luong AU, Magliocca KR, Markovic SN, Matnjani G, McKean EL, Meço C, Mendenhall WM, Michel L, Na'ara S, Nicolai P, Nuss DW, Nyquist GG, Oakley GM, Omura K, Orlandi RR, Otori N, Papagiannopoulos P, Patel ZM, Pfister DG, Phan J, Psaltis AJ, Rabinowitz MR, Jr RM, Rimmer R, Rosen MR, Sanusi O, Sargi ZB, Schafhausen P, Schlosser RJ, Sedaghat AH, Senior BA, Shrivastava R, Sindwani R, Smith TL, Smith KA, Snyderman CH, Solares CA, Sreenath SB, Stamm A, Stölzel K, Sumer B, Surda P, Tajudeen BA, Thompson LDR, Thorp BD, Tong CCL, Tsang RK, Turner JH, Turri-Zanoni M, Udager AM, van Zele T, VanKoevering K, Welch KC, Wise SK, Witterick IJ, Won TB, Wong SN, Woodworth BA, Wormald PJ, Yao WC, Yeh CF, Zhou B, Palmer JN. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors. Int Forum Allergy Rhinol, 2023. e-Pub 2023.
      12. Na’ara S, Subramaniam N, Deganello N, Shinnawi S, Billan S, Mattavelli S, Ferrari M, Balasubramanian D, Thankappan K, Iyer S, Gil Z. Primary Tumor Staging for Oral Cancer and a Proposed Modification Incorporating Perineural Invasion: An International Multicenter Study. Adv Biol (Weinh), 2023. e-Pub 2023.
      13. Cohen-Vaizer M, Dreyfuss M, Na’ara S, Shinnawi S, Laske R. The impact of surgical expertise on the cost-effectiveness of stapes surgery. Audiol Neurootol, 2023. e-Pub 2023.
      14. Chen H, Zhao W, Na’ara S, Gleber-Netto F, Xie T, Ali S, Thompson Z, Buell J, Stafford H, Nagarajan P, Davies M, Wong M, Migden M, Sharma P, Myers J, Gross N, Amit M. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precis Oncol, 2023. e-Pub 2023.
      15. Mukherjee A, Ha P, Wai K, Na'ara S. The Role of ECM Remodeling, EMT, and Adhesion Molecules in Cancerous Neural Invasion: Changing Perspectives. Adv Biol (Weinh), 2022. e-Pub 2022.
      16. Karawani H, Matanis W, Na'ara S. Middle ear effusion and newborn hearing screening. Eur Arch Otorhinolaryngol, 2022. e-Pub 2022.
      17. Demir I, Reyes C, Alrawashdeh W, Ceyhan G, Deborde S, Friess H, Görgülü K, Istvanffy R, Jungwirth D, Kuner R, Maryanovich M, Na’ara S, Renders S, Saloman J, Scheff N, Steenfadt H, Stupakov P, Thiel V, Verma D, Yilmaz B, White R, Wang T, Wong R, Frenette P, Gil Z, Davis B. Future directions in preclinical and translational cancer neuroscience research. Nature Cancer, 2021. e-Pub 2021.
      18. Na'ara S, Aronov M, Gil Z, Gordin A. Can Tonsillectomy Be Safely Performed by Residents? A Comparative Retrospective Study. Ann Otol Rhinol Laryngol, 2021. e-Pub 2021.
      19. Shinnawi S, Kopaev I, Na’ara S, Eran A, Sviri G, Ostrovsky D, Gil Z. Long-Term Quality of Life after Endoscopic Pituitary Adenoma Surgery with Nasoseptal Flap Reconstruction. Rambam Maimonides Med J, 2021. e-Pub 2021.
      20. Forner D, Hueniken K, Yoannidis T, Wittreck I, Monteiro E, Zadeh G, Gullane P, Snyderman C, Wang E, Gardner P, Valappil B, Fliss D, Ringel B, Gil Z, Na’ara S, Ooi E, Goldstein D, Muhanna N, Gentili F, De Almeida J. Psychometric testing of the Skull Base Inventory health-related quality of life questionnaire in a multi-institutional study of patients undergoing open and endoscopic surgery. Qual Life Res, 2020. e-Pub 2020.
      21. Demir I, Reyes C, Alrawashdeh W, Ceyhan G, Deborde S, Friess H, Görgülü K, Istvanffy R, Jungwirth D, Kuner R, Maryanovich M, Na’ara S, Renders S, Saloman J, Scheff N, Steenfadt H, Stupakov P, Thiel V, Verma D, Yilmaz B, White R, Wang T, Wong R, Frenette P, Gil Z, Davis B. Clinically Actional Strategies for Studying Neural Influences in Cancer. Cancer Cell, 2020. e-Pub 2020.
      22. Na'ara S, Sayegh W, Nassar N, Shinnawi S, Gil Z, Gordin A. Cold Versus Hot Adenoidectomy: A Prospective, Randomized Controlled Trial. Int J Pediatr Otorhinolaryngol, 2020. e-Pub 2020.
      23. Na'ara S, Kaptzan B, Gil Z, Ostrovsky D. Endoscopic Septoplasty Versus Traditional Septoplasty for Treating Deviated Nasal Septum: A Prospective, Randomized Controlled Trial. Ear Nose Throat J, 2020. e-Pub 2020.
      24. Na’ara S, Mukherjee A, Billan S, Gil Z. Contemporary multidisciplinary management of sinonasal mucosal melanoma. Onco Targets Ther, 2020. e-Pub 2020.
      25. Aashiq M, Silverman DA, Na'ara S, Takahashi H, Amit M. Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies. Cancers, 2019. e-Pub 2019.
      26. Na'ara S, Mahameed K, Amit M, Cohen JT, Weiler-Sagie M, Albitsky I, Gil Z, Billan S. Efficacy of posttreatment radioiodine scanning in patients with differentiated thyroid cancer. Head Neck, 2019. e-Pub 2019.
      27. Na’ara S, Vainer I, Amit M, Gordin A. Foreign body aspiration in infants and older children, a comparative study. Ear, Nose & Throat Journal, 2019. e-Pub 2019.
      28. Amit M, Na'ara S, Friedman E, Vladovski E, Wasserman T, Milman N, Gil Z. RET, a targetable driver of pancreatic adenocarcinoma. Int J Cancer, 2018. e-Pub 2018.
      29. Gil Z, Fridman E, Na'ara S. Reply to Patients with revised surgical resection margins are best studied as a distinct group. Cancer, 2018. e-Pub 2018.
      30. Hijab A, Turgeman I, Na'ara S, Long BS. Long Term Negative Predictive Value of Post-Treatment FDG PET/CT Scan in Nasopharyngeal Carcinoma. Clinics in Oncology, 2018. e-Pub 2018.
      31. Fridman E, Na'ara S, Gil Z. Reply to Are adjuvant radiotherapy outcomes really better in patients with early-stage oral cavity squamous cell carcinoma?. Cancer, 2018. e-Pub 2018.
      32. Na'ara S, Amit M, Gil Z. L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression. Oncogene, 2018. e-Pub 2018.
      33. Fridman E, Na'ara S, Agarwal J, Amit M, Bachar G, Villaret AB, Brandao J, Cernea CR, Chaturvedi P, Clark J, Ebrahimi A, Fliss DM, Jonnalagadda S, Kohler HF, Kowalski LP, Kreppel M, Liao CT, Patel SG, Patel RS, Robbins KT, Shah JP, Shpitzer T, Yen TC, Zöller JE, Gil Z. International Consortium for Outcome Research in Head and Neck Cancer. The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study. Cancer, 2018. e-Pub 2018.
      34. Amit M, Na'ara S, Hanna EY. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma. Curr Oncol Rep, 2018. e-Pub 2018.
      35. Amit M, Na'ara S, Francis D, Matanis W, Zolotov S, Sagie MW, Malkin L, Billan S, Charas T, Gil AZ. Radioactive Iodine Therapy Response In Papillary Thyroid Carcinoma is post-translationally regulated by the GPIT complex. Natl Cancer Inst, 2017. e-Pub 2017.
      36. Na'ara S, Amit M, Billan S, Cohen JT, Gil Z. Surgical Treatment Of Locally Advanced Well Differentiated Thyroid Carcinoma. Harefuah, 2017. e-Pub 2017.
      37. Amit M, Na'ara S, Trejo-Leider L, Sharma K, Ramer N, Ramer I, Agbetoba A, Glick J, Yang X, Lei D, Bjoerndal K, Godballe C, Mücke T, Klaus-Dietrich W, Eckardt AM, Copelli C, Sesenna E, Palmer F, Ganly I, Gil Z. Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study. Head Neck, 2017. e-Pub 2017.
      38. Amit M, Na'ara S, Leider-Trejo L, Binenbaum Y, Kulish N, Fridman E, Shabtai-Orbach A, Wong RJ, Gil Z. Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma. Oncogene, 2017. e-Pub 2017.
      39. Amit M, Na'ara S, Gil Z. Mechanisms of Cancer Dissemination along Nerves. Nat Rev Cancer, 2016. e-Pub 2016.
      40. Na'ara S, Gil Z, Amit M. In Vitro Modeling of Cancerous Neural Invasion. J Vis Exp, 2016. e-Pub 2016.
      41. Amit M, Eran A, Billan S, Fridman E, Na'ara S, Charas T, Gil Z. Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem. J Neurol Surg B Skull Base, 2016. e-Pub 2016.
      42. Na'ara S, Amit M, Gil Z, Billan S. Plasmacytoma of the Skull Base: A Meta-Analysis. J Neurol Surg B Skull Base, 2016. e-Pub 2016.
      43. Na'ara S, Amit M, Fridman E, Gil Z. Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma. Rambam Maimonides Med J, 2016. e-Pub 2016.
      44. Amit M, Na'ara S, Leider-Trejo L, Akrish S, Cohen JT, Billan S, Gil Z. Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: A prospective randomized controlled study. Head Neck, 2015. e-Pub 2015.
      45. Binenbaum Y, Na'ara S, Gil Z. Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resist Updat, 2015. e-Pub 2015.
      46. Amit M, Na'ara S, Sharma K, Ramer N, Ramer I, Agbetoba A, Glick J, Yang X, Lei D, Bjoerndal K, Godballe C, Mücke T, Klaus-Dietrich W, Eckardt AM, Copelli C, Sesenna E, Palmer F, Ganly I, Gil Z. Elective neck dissection in patients with head and neck adenoid cystic carcinoma: an international collaborative study. Ann Surg Oncol 22(4):1353-9, 2015. e-Pub 2015.
      47. Cohen JT, Gil Z, Binenbaum Y, Na'ara S, Amit M. An orthotopic mouse model of laryngeal squamous cell carcinoma. Ann Otol Rhinol Laryngol, 2015. e-Pub 2015.
      48. Shabtay-Orbach A, Amit M, Binenbaum Y, Na'ara S, Gil Z. Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor. Int J Cancer, 2014. e-Pub 2014.
      49. Amit M, Na'ara S, Binenbaum Y, Billan S, Sviri G, Cohen JT, Gil Z. Treatment and Outcome of Patients with Skull Base Chordoma: A Meta-analysis. J Neurol Surg B Skull Base, 2014. e-Pub 2014.
      50. Na'ara S, Amit M, Billan S, Cohen JT, Gil Z. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis. Ann Surg Oncol 21(9):3056-62, 2014. e-Pub 2014.
      51. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Na'ara S, Sathishkumar HN, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Gong D, Tallon De Torres P, Tao DL, Davidson TM, Ajami N, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer P, D’Silva N, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature.

      Book Chapters

      1. Na'ara S, Gil Z. Assessment of surgical margins. In: Textbook of Oral Cancer - A Multidisciplinary Guide to Prevention, Diagnosis and Management. Springer-Nature, 2020.
      2. Na’ara S, Gil Z. Thyroid surgery. In: Diseases of the thyroid and parathyroid glands. Plural Publishing, 2019.
      3. Amit M, Na'ara S, Gil Z. Robotics in Surgery. In: Atlas of Head and Neck Robotic Surgery, 2017.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 07, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top